Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study
Conditions: Breast Cancer Female; Cardiometabolic Syndrome; Metabolism Disorder, Lipid; Autonomic Dysfunction; Cardiovascular Diseases in Old Age Interventions: Behavioral: HIIT program (8 weeks); Behavioral: MPI program (8 weeks) Sponsors: University of Valencia; Generalitat Valenciana Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
CARDIOCARE Prospective Clinical Study
Conditions: Breast Cancer Interventions: Behavioral: Control group; Behavioral: Intervention group Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
A Study of Changes in Thinking and Memory Processes Over Time in Breast Cancer Survivors
Conditions: Breast Cancer Survivors Interventions: Other: Assessments; Other: Assessment (Survivors Only); Other: APOE and DNA Isolation Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Whole Genome Sequencing in Breast Cancer
Conditions: Breast Cancer Interventions: Other: no intervention needed Sponsors: Inocras Korea Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; HER2-negative Breast Cancer; Metastatic Castration-resistant Prostate Cancer (mCRPC); Pancreatic Cancer; Platinum-resistant Ovarian Cancer (PROC) Interventions: Drug: NUV-1511 Sponsors: Nuvation Bio Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)
Conditions: Breast Cancer Interventions: Device: Pulsed electromagnetic fields (PEMFs); Drug: Anthracycline-based chemotherapy Sponsors: National University Hospital, Singapore; National University of Singapore Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
Conditions: Female Breast Cancer Interventions: Other: Completion of questionnaires Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Pulsed Electromagnetic Fields for Analgesia Post Mastectomy
Conditions: Female Breast Cancer; Post Operative Pain Interventions: Device: Active AlgoCare; Device: Non-active AlgoCare Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Brain Metastasis Development Mechanism in BCBM Patients
Conditions: Breast Cancer; Brain Metastasis Interventions: Procedure: WGS/TME evaluation Sponsors: Samsung Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
Conditions: HER2-positive Breast Cancer Interventions: Diagnostic Test: GeoMx data analysis with clinical outcome Sponsors: Samsung Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Anlotinib; Drug: Trastuzumab deruxtecan Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
Conditions: Advanced Breast Cancer; Metastatic Breast Cancer Interventions: Drug: Hydroxychloroquine; Drug: Sacituzumab Govitecan; Drug: Trastuzumab Deruxtecan Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Psychosexuological Interventions to Support Sexual Function in Breast Cancer Patients
Conditions: Breast Cancer Interventions: Other: Control Group; Other: Psychosexological intervention Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer
Conditions: Recurrent Breast Cancer Interventions: Procedure: Reoperative Sentinel Lymph Node Biopsy Sponsors: Hospital Clinic of Barcelona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
Conditions: HER2-positive Breast Cancer; HER2-positive Gastric Cancer; HER2 Positive Solid Tumors; HER2 Amplification; Colorectal Cancer Interventions: Drug: ELVN-002; Drug: Trastuzumab; Drug: 5-Fluorouracil; Drug: Oxaliplatin; Drug: Capecitabine; Drug: Eribulin; Drug: paclitaxel; Drug: Leucovorin Sponsors: Enliven Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
